Literature DB >> 24970716

Validation of lactate level as a predictor of early mortality in acute decompensated heart failure patients who entered intensive care unit.

Tomoharu Kawase1, Mamoru Toyofuku2, Tasuku Higashihara3, Yousaku Okubo3, Lisa Takahashi3, Yuzo Kagawa3, Kenichi Yamane3, Shinji Mito3, Hiromichi Tamekiyo3, Masaya Otsuka3, Tomokazu Okimoto3, Yuji Muraoka3, Yoshiko Masaoka3, Nobuo Shiode3, Yasuhiko Hayashi3.   

Abstract

BACKGROUND: The significance of routine measurement of lactate level is unclear in patients with critical acute decompensated heart failure (ADHF). METHODS AND
RESULTS: Consecutive 754 patients who were admitted to the intensive care unit (ICU) in our hospital from January 2007 to March 2012 and given a diagnosis of ADHF were eligible for retrospective entry into the registry. Lactate level was measured on admission from routine arterial blood sample and we investigated by comparing the lactate level and parameters of conventional in-hospital mortality predictors. Among the patients, 88 (12%) died during hospitalization. The lactate level had great power to predict in-hospital mortality, as suggested by the c-statistics of 0.71. The occurrence of in-hospital death was more pronounced in patients with high levels of lactate (>3.2mmol/l) and the tendency was observed in patients in both the acute coronary syndrome (ACS) group and non-ACS group. In multivariate analysis, elevated lactate levels remained an independent predictor of in-hospital death (odds ratio, 2.14; 95% confidence interval, 1.10-4.21; p=0.03).
CONCLUSIONS: Elevated levels of arterial lactate on admission were related to worse in-hospital mortality in patients with ADHF either with or without ACS, suggesting that the presence of high lactate in patients who enter the ICU with ADHF could help stratify the initial risk of early mortality.
Copyright © 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute decompensated heart failure; Biomarker; Lactate; Mortality

Mesh:

Substances:

Year:  2014        PMID: 24970716     DOI: 10.1016/j.jjcc.2014.05.006

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  12 in total

1.  Association of Different Lactate Indices with 30-Day and 180-Day Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: A Retrospective Cohort Study.

Authors:  Long Hu; Wei Lin; Tiancheng Xu; Dongjie Liang; Guangze Xiang; Rujie Zheng; Changzuan Zhou; Qinxue Dai; Danyun Jia
Journal:  Ther Clin Risk Manag       Date:  2020-09-02       Impact factor: 2.423

Review 2.  Clinical significance of lactate in acute cardiac patients.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2015-08-26

3.  A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential.

Authors:  Jessica A Palmer; Alan M Smith; Vitalina Gryshkova; Elizabeth L R Donley; Jean-Pierre Valentin; Robert E Burrier
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

4.  Serum Anion Gap Is Associated with All-Cause Mortality among Critically Ill Patients with Congestive Heart Failure.

Authors:  Yiyang Tang; Wenchao Lin; Lihuang Zha; Xiaofang Zeng; Xiaoman Zeng; Guojun Li; Zhenghui Liu; Zaixin Yu
Journal:  Dis Markers       Date:  2020-11-16       Impact factor: 3.434

5.  The value of lactate/albumin ratio for predicting the clinical outcomes of critically ill patients with heart failure.

Authors:  Wenqin Guo; Lingyue Zhao; Hanjun Zhao; Fanfang Zeng; Changnong Peng; Wenyu Guo; Hongbing Yan
Journal:  Ann Transl Med       Date:  2021-01

6.  Chronic Lactate Exposure Decreases Mitochondrial Function by Inhibition of Fatty Acid Uptake and Cardiolipin Alterations in Neonatal Rat Cardiomyocytes.

Authors:  Iñigo San-Millan; Genevieve C Sparagna; Hailey L Chapman; Valerie L Warkins; Kathryn C Chatfield; Sydney R Shuff; Janel L Martinez; George A Brooks
Journal:  Front Nutr       Date:  2022-03-04

7.  Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.

Authors:  Grunde Gjesdal; Oscar Ö Braun; J Gustav Smith; Fredrik Scherstén; Patrik Tydén
Journal:  BMC Cardiovasc Disord       Date:  2018-01-18       Impact factor: 2.298

Review 8.  Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications.

Authors:  Jorge Ferreira
Journal:  ESC Heart Fail       Date:  2017-09-28

Review 9.  The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF.

Authors:  Nobuyuki Kagiyama; Yuya Matsue
Journal:  Anatol J Cardiol       Date:  2018-08       Impact factor: 1.596

10.  Time-weighted lactate as a predictor of adverse outcome in acute heart failure.

Authors:  Giorgio Bosso; Valentina Mercurio; Nermin Diab; Antonio Pagano; Giovanni Porta; Enrico Allegorico; Claudia Serra; Giovanna Guiotto; Fabio Giuliano Numis; Carlo Gabriele Tocchetti; Fernando Schiraldi
Journal:  ESC Heart Fail       Date:  2020-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.